Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2012 | 03-2012 | 12-2011 | 06-2011 | |
| Operating Expenses | 61 | 5 | 0 | 0 |
| Operating Income | -61 | -5 | N/A | N/A |
| Pre-tax Income | -61 | -5 | 0 | 0 |
| Net Income Continuous | -61 | -5 | N/A | 0 |
| Net Income | $-61 | $-5 | $N/A | $0 |
| EPS Basic Total Ops | -0.34 | 0.00 | N/A | N/A |
| EPS Basic Continuous Ops | -0.30 | -0.03 | N/A | N/A |
| EPS Diluted Total Ops | -0.34 | 0.00 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.30 | -0.03 | N/A | N/A |
| EBITDA(a) | $-61 | $-5 | $N/A | $N/A |